Genetic counselling protocols for hereditary non-polyposis colorectal cancer: A survey of UK regional genetics centres

Clinical Genetics

Volumn 63, Issue 3, 2003, Pages 198-204

  Brain, Kate ^a   Soldan, J ^b   Sampson, J ^a   Gray, J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Cardiff Comm Healthcare NHS Trust   (United Kingdom)

Author keywords

Counselling protocols; Genetic counselling; Hereditary non polyposis colorectal cancer; Huntington's disease; Predictive testing

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; COLORECTAL CANCER; CONTROLLED STUDY; EDUCATION; FAMILIAL CANCER; GENETIC COUNSELING; HEALTH SURVEY; HUMAN; NOMENCLATURE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC COUNSELING; GENETIC SCREENING; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 0041630892     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00039.x     Document Type: Article

References (27)

1. Crauford D, Tyler A. Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium. J Med Genet 1992: 29: 915-918.
2. Geller G, Botkin JR, Green MJ et al. Genetic testing for susceptibility to adult-onset cancer: the process and content of informed consent. JAMA 1997: 277: 1467-1474.
3. Harper PS. Huntington's Disease. London: W. B. Saunders, 1992.
4. Kessler S. Teaching and counseling. J Genet Counsel 1997: 6: 287-295.
5. Kessler S. Psyche and Helix: Psychological Aspects of Genetic Counseling. New York: Wiley, 2000.
6. Shoda Y, Mischel W, Miller SM, Diefenbach M, Daly MB, Engstrom PF. Psychological interventions and genetic testing: facilitating informed decisions about BRCA1/2 cancer susceptibility. J Clin Psychol Med Settings 1998: 5: 3-17.
7. Soldan J, Street E, Gray J, Binedell J, Harper P. Psychological model for presymptomatic test interviews: lessons learned from Huntington Disease. J Genet Counsel 2000: 9: 15-31.
8. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M. The psychological consequences of predictive testing for Huntington's Disease. N Engl J Med 1992: 327: 1401-1405.
9. Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman J-J, Cloostermans T, Demyttenaere K. Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of test result on reproductive decision making. J Med Genet 1996: 33: 737-743.
10. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ. Three-year follow-up after presymptomatic testing for Huntington's Disease in tested individuals and partners. Health Psychol 1997: 16: 20-35.
11. Marteau TM, Croyle RT. Psychological responses to genetic testing. BMJ 1998: 316: 693-696.
12. Copley TT, Wiggin S, Dufrasne S, Bloch M, Adam S. Are we all of one mind? Clinician and patient opinions regarding the development of a service protocol for presymptomatic testing for Huntington's Disease. Am J Med Genet 1995: 58: 59-69.
13. Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000: 8: 731-738.
14. Stern H, Lagarde W. Genetics of hereditary colon cancer: a model for prevention. Can J Surg 1998: 41: 345-350.
15. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in hereditary nonpolyposis colorectal cancer (HNPCC) families. Gastroenterology 1995: 108: 1405-1411.
16. Bennett G, Rudzki Z, Cole S, Young G, Suthers G. The impact of molecular diagnosis on familial colorectal cancer. Clin Chem Lab Med 1998: 36: 641--644.
17. Babul R, Shelin A, Kremer B et al. Attitudes towards direct predictive testing for the Huntington disease gene: relevance for other adult-onset disorders. JAMA 1993: 270: 2321-2325.
18. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. Int J Cancer (Pred Oncol) 1996: 69: 58-61.
19. Decruyenaere M, Evers-Kiebooms G, Boogaerts A et al. Non-participation in predictive testing for Huntington's Disease: individual decision-making, personality and avoidant behaviour in the family. Eur J Hum Genet 1997: 5: 351-363.
20. Dudok deWit AC, Tibben A, Duivenvoorden HJ et al. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. J Med Genet 1997: 34: 382-390.
21. Evers-Kiebooms G. Letter to the editor: a personal view on reviewing the psychological consequences of predictive genetic testing for late onset disease. Eur J Hum Genet, 2001: 9: 392-393.
22. Lerman C, Hughes C, Trock BJ et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999: 281: 1618-1622.
23. Lerman C, Biesecker B, Benkendorf JL et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997: 89: 148-157.
24. Aktan-Collan K, Mecklin J-P, de la Chapelle A, Peltomäki P, Uutela A, Kääriäinen H. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 1999: 37: 108-113.
25. Evans DGR, Maher ER, Macleod R, Rhodri-Davies D, Crauford D. Uptake of presymptomatic testing for cancer predispositions. J Med Genet 1997: 34: 746-748.
26. Audrain J, Rimer B, Cella D et al. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol 1998: 16: 133-138.
27. Lodder LN, Frets PG, Trijsburg RW et al. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? J Med Genet 1999: 36: 906-913.